Zachary Roberts
Chief Tech/Sci/R&D Officer en ALLOGENE THERAPEUTICS, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Zachary Roberts is currently the Chief Medical Officer & Executive Vice President at Allogene Therapeutics, Inc. He previously worked as the Director-Clinical Medical Research at Amgen, Inc. in 2015, the Vice President-Clinical Development at Kite Pharma, Inc. from 2018 to 2019, and the Chief Medical Officer at Instil Bio, Inc. from 2020 to 2022.
Dr. Roberts obtained his undergraduate degree from the University of Maryland and his doctorate from the University of Maryland School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/01/2024 | 515 253 ( 0.30% ) | 2 M $ | 31/03/2024 |
Cargos activos de Zachary Roberts
| Empresas | Cargo | Inicio |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 03/01/2023 |
Antiguos cargos conocidos de Zachary Roberts.
| Empresas | Cargo | Fin |
|---|---|---|
| INSTIL BIO, INC. | Chief Tech/Sci/R&D Officer | 11/11/2022 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 01/05/2019 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/07/2015 |
Formación de Zachary Roberts.
| University of Maryland | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Zachary Roberts
